Ovid Therapeutics Inc (NAS:OVID) Stock News, Headlines & Updates
Ovid Therapeutics Inc Stock News from GuruFocus
- 1
Aug 13, 2024
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Marketwired • 7:00am
Aug 08, 2024
Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer
Marketwired • 7:00am
Aug 03, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 4:00pm
Aug 02, 2024
OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm
PRNewswire • 10:00am
OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm
Business Wire • 7:00pm
Aug 01, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 6:00pm
Jul 30, 2024
Ovid Therapeutics to Present at Upcoming August Investor Conferences
Marketwired • 7:00am
Jul 26, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 12:00pm
Jul 25, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 8:00pm
Jul 23, 2024
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
Marketwired • 8:00am
Jul 20, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 4:00pm
Jul 19, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 9:00pm
Jul 12, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 10:00am
Jul 10, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 6:00pm
eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
Marketwired • 7:00am
Jul 07, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 1:00pm
Jul 02, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 8:00am
Jul 01, 2024
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
Marketwired • 7:00am
Jun 30, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 4:00pm
Jun 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 3:00pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
PRNewswire • 3:00pm
Jun 22, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
Marketwired • 10:00am
Jun 17, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news